AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. RCKT
  4. [Form 4] Rocket Pharmaceuticals, Inc. Insider Trading Activity

[Form 4] Rocket Pharmaceuticals, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Filing content is currently unavailable.

Source:

Stock RCKT logo
Rocket Pharmaceu

NASDAQ:RCKT

RCKT Rankings

#3658 Ranked by Market Cap
N/A Ranked by Dividends

RCKT Latest News

Aug 20, 2025
Rocket Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on the Pivotal Phase 2 Trial of RP-A501 for the Treatment of Danon Disease
Aug 7, 2025
Rocket Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Progress
Jul 24, 2025
Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs
Jul 17, 2025
Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A601 Gene Therapy for PKP2-Arrhythmogenic Cardiomyopathy
Jun 30, 2025
Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy

RCKT Latest SEC Filings

Aug 20, 2025
[Form 4] Rocket Pharmaceuticals, Inc. Insider Trading Activity
Aug 20, 2025
[Form 4] Rocket Pharmaceuticals, Inc. Insider Trading Activity
Aug 20, 2025
[Form 4] Rocket Pharmaceuticals, Inc. Insider Trading Activity
Aug 20, 2025
[Form 4] Rocket Pharmaceuticals, Inc. Insider Trading Activity
Aug 20, 2025
[8-K] Rocket Pharmaceuticals, Inc. Reports Material Event

RCKT Stock Data

326.95M
104.27M
3.03%
91.39%
10.41%
Biotechnology
Pharmaceutical Preparations
United States
NEW YORK